Skip to main content

Find Clinical Trials

Home
Conditions
Glioblastoma, IDH-wildtype

Clinical trial condition

Glioblastoma, IDH-wildtype

Explore clinical trials studying Glioblastoma, IDH-wildtype. Study availability and eligibility vary by location and protocol.

35 public trials 25 recruiting studies

Refine in advanced search Browse all conditions

Glioblastoma, IDH-wildtype trial results

Active, not recruiting

Ultrasound-based Blood-brain Barrier Opening and Albumin-bound Paclitaxel and Carboplatin for Recurrent Glioblastoma

NCT04528680

Conditions: Astrocytoma, GBM, Glioblastoma, +12 more
Locations: Northwestern Memorial Hospital Chicago, Illinois, United States

View Trial Details

Completed

Regorafenib With Temozolomide With or Without RT in MGMT-Methylated, IDH Wild-type GBM Patients

NCT06095375

Conditions: Astrocytoma, Glioblastoma, Glioblastoma, IDH-wildtype, +9 more
Locations: Istituto Oncologico Veneto IRCCS Padova, Italy

Humanitas Research Hospital Rozzano, Italy

View Trial Details

Completed

BIOhabitats: Biological Validation of Vascular Habitats Within Astrocytoma Grade 4 at Molecular, Cellular, and Histopathological Levels

NCT05375318

Conditions: Astrocytoma, Astrocytoma, Grade IV, Glioblastoma, +14 more
Locations: Biomedical Data Science Lab. Universitat Politècnica de València Valencia, Spain

View Trial Details

Completed

Biomolecular Analysis for Predicting Response to Regorafenib

NCT05759195

Conditions: Astrocytoma, Glioblastoma, Glioblastoma, IDH-wildtype, +8 more
Locations: Fondazione Policlinico Universitario A. Gemelli IRCCS Rome, Italy

View Trial Details

Completed

SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors

NCT03434262

Conditions: Anaplastic Astrocytoma, Anaplastic Ependymoma, Anaplastic Ganglioglioma, +92 more
Locations: St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details